Why the study?
Hypertensive disorders of pregnancy increase premature CVD risk, but existing cardiovascular prediction models do not adequately capture risks in young women.
Can a developed model accurately predict the 10-year risk of premature CVD and mortality in women with hypertensive disorders of pregnancy?
Can a developed model accurately predict the 10-year risk of premature CVD and mortality in women with hypertensive disorders of pregnancy?
A newly developed model for predicting 10-year premature CVD risk in women with hypertensive disorders of pregnancy showed modest discrimination and requires further refinement and external validation before clinical use.
This risk model is not yet ready for clinical use; leaves open the need for external validation and refinement.
Background Hypertensive disorders of pregnancy (HDP) are associated with an increased risk of premature cardiovascular disease (CVD), but existing cardiovascular prediction models do not adequately capture risks in young women. We developed a model to predict the 10-year risk of premature CVD and mortality among women who have HDP. Methods and Results Using a population-based cohort of women with HDP who delivered between April 1989 and March 2017 in Quebec, Canada, we developed a 10-year CVD risk model using Cox proportional hazards regression. Women aged 18 to 45 years were followed from their first HDP-complicated delivery until March 2018. We assessed performance of the model based on discrimination, calibration, and risk stratification ability. Internal validity was assessed using the bootstrap method. The cohort included 95 537 women who contributed 1 401 084 person-years follow-up. In total, 4024 (4.2%) of women were hospitalized for CVD, of which 1585 events (1.6%) occurred within 10 years of follow-up. The final model had modest discriminatory performance (area under the receiver operating characteristic curve, 0.66; 95% CI, 0.65-0.67) and good calibration with slope of 0.95 and intercept of -0.19. There was moderate classification accuracy (likelihood ratio+: 5.90; 95% CI, 5.01-6.95) in the highest-risk group upon risk stratification. Conclusions Overall, our model had modest performance in predicting the 10-year risk of premature CVD for women with HDP. We recommend the addition of clinical variables, and external validation, before consideration for clinical use.
No takes yet. Share an insight, caveat, or question.
Ukah et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: